<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[management and pharmaceutical company Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/management+and+pharmaceutical+company.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to management and pharmaceutical company]]></description>
	<s:counts start="0" returned="20" found="55" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Novartis, Boehringer Start Using Twitter Accounts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001062/novartis-boehringer-start-using-twitter-accounts/]]></link>
		<description><![CDATA[AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive.    Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Feb 2009 10:02:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/twitter.html"><![CDATA[Twitter]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/bi+site.html"><![CDATA[BI Site]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/business+intelligence.html"><![CDATA[Business Intelligence]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb Plans $2.5 Bil. in Layoffs, Cuts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000386/bristol-myers-squibb-plans-25-bil-in-layoffs-cuts/]]></link>
		<description><![CDATA[Bristol-Myers Squibb made a presentation this morning at the Credit Suisse Healthcare Conference that showed CFO John Marc-Huet wants to save the company $2.5 billion in "productivity initiatives." He's going to squeeze these out of "headcount and related costs" -- which sounds like a euphemism for layoffs.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 13 Nov 2008 12:47:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/layoff.html"><![CDATA[Layoff]]></category>
		<category domain="http://resources.bnet.com/topic/foreign-exchange.html"><![CDATA[Foreign-exchange]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/john+marc-huet.html"><![CDATA[John Marc-Huet]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/currency+%2526+foreign+exchange.html"><![CDATA[Currency & Foreign Exchange]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Obama and Big Pharma: The Case for Pfizer]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F105120-obama-and-big-pharma-the-case-for-pfizer%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Shiv Kapoor submits:  The street has long been concerned over the fate of big pharma under Obama.  Affordability and access to healthcare is important for America.  So too is innovation.  America has long led the world in commerce.  Its leadership has sprung from strong corporations with access to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 10 Nov 2008 11:25:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/america.html"><![CDATA[America]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/shiv+kapoor.html"><![CDATA[Shiv Kapoor]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/shiv+kapoor.html"><![CDATA[Shiv Kapoor]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Glaxo Wins Most Ethical, FDA Lacks Committee Leadership, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000335/pharma-roundup-glaxo-wins-most-ethical-fda-lacks-committee-leadership-and-more/]]></link>
		<description><![CDATA[GlaxoSmithKline tops ethics rankings, three out of four FDA advisory committees lack permanent leadership, great expectations lead to failed pharma alliances, Europe delays pharma bill. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 24 Oct 2008 16:58:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/ethics.html"><![CDATA[Ethics]]></category>
		<category domain="http://resources.bnet.com/topic/business+ethics.html"><![CDATA[Business Ethics]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Corporate Espionage Allegations Reveal Storm in a Teacup at Pharma Conference]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000233/corporate-espionage-allegations-reveal-storm-in-a-teacup-at-pharma-conference/]]></link>
		<description><![CDATA[There was a behind-the-scenes drama at the Pharma Competitive Intelligence conference in New Jersey last week involving allegations that the organizer of the conference engaged in "misappropriation of company assets" and that subpoenas have been sent to Pfizer, Johnson & Johnson, Sanofi-Aventis, Merck, Novartis, and Bristol-Myers Squibb.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 23 Sep 2008 09:08:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[Conference]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Would You Logroll for the Boss?]]></title>
		<link><![CDATA[http://blogs.bnet.com/ethics/?p=219]]></link>
		<description><![CDATA[Where's the line when it comes to kissing up? As BNET Pharma Industry blogger Jim Edwards pointed out this week, when GlaxoSmithKline SVP of managed markets and neurohealth, Stephen Stefano, came out recently with a new management book (called "Passion and Ice,") a group of company and pharma industry colleagues...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 15 Aug 2008 11:00:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/michael+mattis.html"><![CDATA[Michael Mattis]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Harris Poll: Is Your Industry Loved or Loathed?]]></title>
		<link><![CDATA[http://blogs.bnet.com/bnet1/?p=526]]></link>
		<description><![CDATA[  	The Find: An annual poll reveals which industries are rising in public esteem and which are tanking.  	The Source: The Harris Poll's annual survey of public attitudes to twenty industries.    The Takeaway: Every year Harris asks 1,000 American adults for their views on whether...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 09:09:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/jessica+stillman.html"><![CDATA[jessica stillman]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
	</item>
	<item>
		<title><![CDATA[High Performance In Sight: Pharmaceutical Company Saves Money By Streamlining IT Infrastructure]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1181163]]></link>
		<description><![CDATA[To sustain revenues in a competitive market and invest more aggressively in research and development, one of the world's largest pharmaceutical companies made a strategic decision to reduce US$100 million from its IT budget. IT standardization was the first item on the agenda. Accenture marshalled a team from Accenture Technology...]]></description>
		<s:doctype><![CDATA[Case studies]]></s:doctype>
		<pubDate>Wed, 23 Jul 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/it+infrastructure.html"><![CDATA[IT Infrastructure]]></category>
		<category domain="http://resources.bnet.com/topic/information+technology.html"><![CDATA[Information Technology]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/high-performance.html"><![CDATA[High-performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/itil.html"><![CDATA[ITIL]]></category>
		<category domain="http://resources.bnet.com/topic/process+improvement.html"><![CDATA[Process Improvement]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/it+services.html"><![CDATA[It Services]]></category>
		<category domain="http://resources.bnet.com/topic/quality.html"><![CDATA[Quality]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Unlocking The Potential For High Performance Through The Pharmaceutical Supply Chain]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=953347]]></link>
		<description><![CDATA[Profitable growth in nowadays' pharmaceutical industry requires a new kind of supply chain - one that plans and executes globally, across the extended enterprise and throughout the product life cycle. By changing their global operating model, redefining core competencies and capabilities, and collaborating with effective partners, including large, strategic customers,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 30 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/supply+chain.html"><![CDATA[Supply Chain]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/high-performance.html"><![CDATA[High-performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Man Bites Dog: Former Merck CEO Blasts High Drug Prices]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100058/man-bites-dog-former-merck-ceo-blasts-high-drug-prices/]]></link>
		<description><![CDATA[Most pharmaceutical companies insist that high drug prices are a natural consequence of the risky business of drug discovery, and that huge profits on marketed drugs are necessary to cover the costs of the 5,000 to 10,000 experimental drugs that fail for every one that succeeds. In fact, there are...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 05 May 2008 01:59:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Pharmaceutical Jobs Offer Good Pay]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=375984]]></link>
		<description><![CDATA[Pharmaceutical jobs belong in the healthcare industry, a fast growing industry. An aging population and new developments in diagnosis and treatment leading to increased use of medication are the main factors leading this growth. The pharmaceutical industry itself is a big part of this growth story. In addition to bringing...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/job.html"><![CDATA[Job]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
	</item>
	<item>
		<title><![CDATA[Products & Services: Strategy Science For Pharma Sales Force Management]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=335029]]></link>
		<description><![CDATA[How well do you believe your sample allocation plan is meeting your business objectives? Is your investment in sampling generating the increased revenue and market share that you think it should? Are you confident that you're not over-sampling and cannibalizing your market? With Fair Isaac's Strategy Science for Pharmaceutical Sampling,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 01 Jan 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sales+force.html"><![CDATA[Sales Force]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/allocation.html"><![CDATA[Allocation]]></category>
		<category domain="http://resources.bnet.com/topic/fair+isaac.html"><![CDATA[Fair Isaac]]></category>
		<category domain="http://resources.bnet.com/topic/strategy+science.html"><![CDATA[Strategy Science]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
	</item>
	<item>
		<title><![CDATA[In the interest of the patient: Convergence across the pharmaceutical and healthcare industries]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=332876]]></link>
		<description><![CDATA[While the pharmaceutical industry is seeking to replace the blockbuster model of drug development, healthcare is struggling with rapidly rising costs. This paper explores how, by collaborating and sharing data, the two industries can realize the full value of the information they collect--and improve patient treatments.   ]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 11 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/convergence.html"><![CDATA[Convergence]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Accenture Electronic Production Execution System: Enhancing Compliance And Performance]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1181155]]></link>
		<description><![CDATA[Quality, price and time to market have always been the driving factors for operational excellence in manufacturing. Increasingly stringent regulations, increased competition created by globalization, shrinking drug pipelines and rising reimbursement favoring generic drugs have been adding pressure to pharmaceutical manufacturing's costs and regulatory compliance. To achieve high performance against...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 10 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[Performance]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[Compliance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manual+data+management.html"><![CDATA[Manual Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/globalization.html"><![CDATA[Globalization]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Valuing R&D Projects In A Portfolio: Evidence From The Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=321671]]></link>
		<description><![CDATA[Understanding the value of a product development project is central to a firm's choice of project portfolio. This is due to interactions with other projects in the portfolio that address the same consumer need and with other projects that require the same development resources. This paper empirically investigates the structure...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sat, 01 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/portfolio.html"><![CDATA[Portfolio]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/product+marketing.html"><![CDATA[Product Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+pennsylvania.html"><![CDATA[University Of Pennsylvania]]></category>
	</item>
	<item>
		<title><![CDATA[Pressure Points: Risk Management in the Pharmaceuticals Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=151558]]></link>
		<description><![CDATA[The report highlights the fact that the pharmaceutical industry is as much as 50 percent riskier than the rest of the S&P 500. Pharmaceutical companies have risk management programs in place and a "controls culture" from being in a highly regulated industry. But their risk management frameworks may not have...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 19 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/kpmg+international.html"><![CDATA[KPMG International]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/risk+management.html"><![CDATA[Risk Management]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Critical Factors for Alliance Formation: Insights From the Deloitte Research Biotech Alliance Survey]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=152365]]></link>
		<description><![CDATA[Convergence of traditional markets and technological platforms is forcing big pharma and big biopharma companies to compete head-to-head in forming alliances with the small biotech companies that now account for a growing share of new drugs in clinical trials. As the level of collaboration increases, alliance formation is becoming more...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 30 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/deloitte+touche+tohmatsu.html"><![CDATA[Deloitte Touche Tohmatsu]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Critical Factors For Alliance Formation]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=953631]]></link>
		<description><![CDATA[Convergence of traditional markets and technological platforms is forcing big pharma and big Biopharma companies to compete head-to-head in forming alliances with the small biotech companies that now account for a growing share of new drugs in clinical trials. As the level of collaboration increases, alliance formation is becoming more...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 30 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/deloitte+touche+tohmatsu.html"><![CDATA[Deloitte Touche Tohmatsu]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Recapturing the Vision: Integrity Driven Performance in the Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=147713]]></link>
		<description><![CDATA[Over the last few years, pharmaceutical companies have seen an increasing level of regulatory scrutiny and highly critical media coverage of the industry's R&D, marketing and manufacturing practices. As a result, there has been a noticeable decline in consumer and investor confidence and a growing degree of negative perceptions about...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 29 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[Performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pricewaterhousecoopers+llp.html"><![CDATA[PricewaterhouseCoopers LLP]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vision.html"><![CDATA[Vision]]></category>
	</item>
	<item>
		<title><![CDATA[A Prescription for Profits, Sustainable Growth and High Performance in China's Pharmaceutical Market]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=149199]]></link>
		<description><![CDATA[With the compelling trade opportunities that exist between multinational pharmaceutical companies and China, pharmaceutical executives worldwide are wondering how to maximize profits and minimize risk in a market that is undergoing revolutionary market change at an almost incomprehensibly rapid rate. The study draws on an in-depth understanding of market drivers...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 18 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/high-performance.html"><![CDATA[High-performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
	</item>
</channel>
</rss>
